Daniel Joseph McCarthy - Jun 12, 2023 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
PRESIDENT
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Jun 12, 2023
Transactions value $
-$31,440
Form type
4
Date filed
6/14/2023, 05:01 PM
Previous filing
Mar 3, 2023
Next filing
Nov 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Sale -$31.4K -1K -0.48% $31.44 206K Jun 12, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2023.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.